Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Kohei Shitara | Researchclopedia

Back to researchers

Kohei Shitara

University of Padua ORCID

1,122

Works

35,281

Citations

79

h-index

315

i10-index

Research Topics

Gastric Cancer Management and Outcomes Colorectal Cancer Treatments and Studies Cancer Immunotherapy and Biomarkers

Affiliations

Tokyo Medical and Dental University2009–2009

Merck & Co., Inc., Rahway, NJ, USA (United States)2017–2017

Ministry of Education, Culture, Sports, Science and Technology2023–2023

Yahoo (United Kingdom)2011–2011

Hyogo Medical University2013–2013

Top Works

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

Yelena Y. Janjigian,Kohei Shitara,et al.

20212,789 citations

Gastrointestinal Tumor Research and Treatment

HER2/EGFR in Cancer Research

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer

Charles S. Fuchs,Toshihiko Doi,et al.

20181,796 citations

Regulatory T cells in cancer immunosuppression — implications for anticancer therapy

Yosuke Togashi,Kohei Shitara,et al.

20191,485 citations

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kohei Shitara,Mustafa Özgüroğlu,et al.

20181,309 citations

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer

Kohei Shitara,Yung‐Jue Bang,et al.

20201,241 citations

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer

Kohei Shitara,Eric Van Cutsem,et al.

20201,097 citations

PD-1 <sup>+</sup> regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer

Takahiro Kamada,Yosuke Togashi,et al.

20191,005 citations

Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)

Shota Fukuoka,Hiroki Hara,et al.

2020902 citations

The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies

Shogo Kumagai,Yosuke Togashi,et al.

2020797 citations